Prognostic significance of metabolic tumor burden by positron emission tomography/computed tomography in patients with relapsed/refractory diffuse large B-cell lymphoma

The aim of the present study was to investigate the feasibility of measuring metabolic tumor burden using [F-18] fluorodeoxyglucose ((18)F-FDG) positron emission tomography/computed tomography (PET/CT) in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) treated with bendamu...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cancer Sci
Auteurs principaux: Tateishi, Ukihide, Tatsumi, Mitsuaki, Terauchi, Takashi, Ando, Kiyoshi, Niitsu, Nozomi, Kim, Won Seog, Suh, Cheolwon, Ogura, Michinori, Tobinai, Kensei
Format: Artigo
Langue:Inglês
Publié: BlackWell Publishing Ltd 2015
Sujets:
Original Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4399031/
https://ncbi.nlm.nih.gov/pubmed/25495273
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12588
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires